Chondrocostal junction syndrome [Tietze]

M13_TIETZE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M94.0 Hospital discharge: ICD-9 — 7336 Cause of death: ICD-10 — M94.0 Cause of death: ICD-9 — 7336 2 out of 7 registries used, show all original rules.	1668
4. Check minimum number of events None	1668
5. Include endpoints None	1668
6. Filter based on genotype QC (FinnGen only)	1472

Control definitions (FinnGen only)

Control exclude: M13_OTHERBONE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M94
Name in latin: Morbus Tietze

NAME	M13_TIETZE
CONTROL_EXCLUDE	M13_OTHERBONE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M940
HD_ICD_9	7336
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M940
COD_ICD_9	7336
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Chondrocostal junction syndrome [Tietze] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	9755	6794	2871
Only index persons	9164	6431	2733
Unadjusted period prevalence (%)
Whole population	0.16	0.19	0.08
Only index persons	0.20	0.24	0.10
Median age at first event (years)
Whole population	53.16	56.14	46.65
Only index persons	52.20	54.94	45.75

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1472	1115	357
Unadjusted period prevalence (%)	0.34	0.40	0.16
Median age at first event (years)	56.27	55.71	58.03

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1552: Matched controls
15520

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

4729.6

307.7

1511

120

R07.4

ICD-10 Finland

Chest pain, unspecified

6.6

305.6

947

2967

R07.3

ICD-10 Finland

Other chest pain

6.3

219.1

460

971

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.8

146.9

931

4360

A11

ICPC

Chest pain NOS

5.3

138.5

328

750

R51.80

ICD-10 Finland

Headache

3.7

118.2

504

1776

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.6

115.8

538

2001

R42

ICD-10 Finland

Dizziness and giddiness

3.1

94.5

570

2436

M54.6

ICD-10 Finland

Pain in thoracic spine

4.4

94.0

267

696

R52.9

ICD-10 Finland

Pain, unspecified

3.9

90.9

316

954

M79.6

ICD-10 Finland

Pain in limb

2.9

87.5

938

5400

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

87.1

931

5346

N03AX16

ATC

[U] pregabalin

3.0

82.6

527

2296

G44.2

ICD-10 Finland

Tension-type headache

3.3

82.2

398

1480

R06.0

ICD-10 Finland

Dyspnoea

2.8

82.2

616

2923

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.8

78.5

586

2762

A02BC02

ATC

pantoprazole; systemic

3.3

77.4

1250

8682

L04

ICPC

Chest symptom/complaint

4.1

74.2

226

616

M54.5

ICD-10 Finland

Low back pain

2.6

71.7

781

4388

N02AX02

ATC

tramadol; systemic, rectal

2.6

70.9

818

4714

A02BC05

ATC

esomeprazole; systemic

2.5

67.9

802

4644

K30

ICD-10 Finland

Functional dyspepsia

3.2

66.7

315

1142

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.8

66.3

441

1932

D01

ICPC

Abdominal pain/cramps general

3.0

62.9

345

1359

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

62.3

593

3079

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.6

58.2

457

2157

M79.1

ICD-10 Finland

Myalgia

2.7

57.6

378

1631

AA1AD

NOMESCO Finland

CT of head and brain

2.4

56.4

563

2961

D06

ICPC

Abdominal pain localized other

3.2

55.7

251

879

M54.4

ICD-10 Finland

Lumbago with sciatica

2.6

55.7

417

1918

R02

ICPC

Shortness of breath/dyspnoea

2.8

55.4

329

1345

N03AX12

ATC

[U] gabapentin; oral

2.7

55.1

361

1553

R53

ICD-10 Finland

Malaise and fatigue

2.4

53.8

559

2980

R07.2

ICD-10 Finland

Precordial pain

7.0

53.0

125

XF400

NOMESCO Finland

ECG with 12 standard connections

2.8

53.0

325

1349

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.9

51.4

118

256

R20.2

ICD-10 Finland

Paraesthesia of skin

3.4

49.9

196

629

M79.7

ICD-10 Finland

Fibromyalgia

4.7

49.6

121

276

7336A

ICD-9 Finland

Other disorders of bone and cartilage, Tietze's disease

+∞

49.2

M03BC01

ATC

orphenadrine (citrate); systemic

2.4

49.2

457

2304

N02AJ06

ATC

codeine and paracetamol; systemic

2.2

48.6

796

5058

N01

ICPC

Headache

2.7

48.1

316

1352

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

47.6

418

2052

A01

ICPC

Pain general/multiple sites

2.9

47.5

260

1012

M25.5

ICD-10 Finland

Pain in joint

2.2

47.4

660

3925

N06AX21

ATC

duloxetine; oral

2.7

46.9

296

1240

A02BC01

ATC

omeprazole; systemic

2.3

46.9

521

2827

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.9

46.6

250

962

L03

ICPC

Low back symptom/complaint

2.2

46.2

602

3480

L01

ICPC

Neck symptom/complaint

2.5

46.1

378

1795

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.6

45.7

306

1320

R00.2

ICD-10 Finland

Palpitations

3.1

45.4

217

782

S06.0

ICD-10 Finland

Concussion

2.8

44.9

257

1022

R03AC02

ATC

salbutamol; inhalant

2.2

44.8

1001

7083

H02AB06

ATC

prednisolone; systemic

2.1

44.3

836

5539

I20.09

ICD-10 Finland

Unstable angina

3.9

43.5

135

369

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

43.2

595

3493

A02BC03

ATC

lansoprazole; oral

2.2

42.8

532

2999

M01AB05

ATC

diclofenac; systemic, rectal

2.2

42.5

1096

8114

M03BX02

ATC

tizanidine; oral

2.2

42.5

1061

7759

R51

ICD-10 Finland

Headache

3.4

41.6

160

505

R09.1

ICD-10 Finland

Pleurisy

6.3

40.6

113

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

40.4

934

6580

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

40.2

510

2885

D02

ICPC

Abdominal pain epigastric

3.2

39.7

173

589

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

39.6

301

1372

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.5

38.8

285

1277

M54.2

ICD-10 Finland

Cervicalgia

2.9

38.6

199

745

Z71.8

ICD-10 Finland

Other specified counselling

2.0

38.4

661

4168

P01AB01

ATC

metronidazole; oral, rectal

2.0

38.4

734

4804

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.4

38.1

320

1524

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.8

37.9

217

859

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

37.8

192

713

R07.0

ICD-10 Finland

Pain in throat

3.0

37.4

182

660

R12

ICD-10 Finland

Heartburn

2.8

37.2

204

789

A02BC04

ATC

rabeprazole; oral

2.8

37.2

208

813

R11

ICD-10 Finland

Nausea and vomiting

2.7

36.3

217

878

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

36.2

389

2050

G43.9

ICD-10 Finland

Migraine, unspecified

3.0

36.1

171

610

J01AA02

ATC

doxycycline; systemic

2.3

35.9

1255

10078

XF402

NOMESCO Finland

ECG with work load test

2.8

35.9

207

822

C01DA14

ATC

isosorbide mononitrate; oral

2.5

35.8

262

1169

N02BE01

ATC

paracetamol; systemic, rectal

3.6

35.3

1457

12585

A02BA02

ATC

ranitidine; systemic

2.2

35.3

359

1848

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

35.2

743

4982

R05

ICPC

Cough

2.0

35.0

498

2912

M01AH05

ATC

etoricoxib; oral

2.0

34.9

1039

7813

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.7

34.8

217

896

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

34.7

239

1035

UJF32

NOMESCO Finland

Coloscopy

2.1

34.3

456

2598

N17

ICPC

Vertigo/dizziness

2.4

34.3

291

1386

N05BA04

ATC

oxazepam; oral

2.0

34.0

497

2929

L17

ICPC

Foot/toe symptom/complaint

2.0

33.8

575

3573

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

33.6

362

1903

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.4

32.9

122

375

M02AA07

ATC

piroxicam; topical

1.9

32.8

601

3821

R51.81

ICD-10 Finland

Facial pain NOS

4.6

32.8

182

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.2

32.4

358

1897

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

32.2

487

2895

R74

ICPC

Upper respiratory infection acute

1.9

32.1

636

4141

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

32.0

196

800

M01AH01

ATC

celecoxib; oral

2.2

32.0

327

1679

C07AB07

ATC

bisoprolol; oral

1.9

32.0

765

5290

N30.0

ICD-10 Finland

Acute cystitis

2.1

32.0

378

2055

L86

ICPC

Back syndrome with radiating pain

3.0

31.8

149

527

K59.09

ICD-10 Finland

Constipation, unspecified

3.0

31.8

155

561

R13

ICD-10 Finland

Dysphagia

2.9

31.7

160

590

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

31.5

258

1207

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

31.3

419

2381

M70.6

ICD-10 Finland

Trochanteric bursitis

2.3

31.1

290

1433

L05

ICPC

Flank/axilla symptom/complaint

2.9

30.8

154

565

M03BC51

ATC

orphenadrine, combinations; systemic

2.0

30.8

475

2837

D11

ICPC

Diarrhoea

2.3

30.7

265

1267

J01MA02

ATC

ciprofloxacin; systemic

1.9

30.7

625

4091

L02

ICPC

Back symptom/complaint

2.4

30.3

237

1085

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

29.9

596

3867

R21

ICPC

Throat symptom/complaint

2.0

29.8

432

2520

R52.2

ICD-10 Finland

Other chronic pain

3.5

29.6

107

323

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.9

29.6

143

M54.8

ICD-10 Finland

Other dorsalgia

3.3

29.3

116

371

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

29.3

191

803

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

29.1

389

2203

A04

ICPC

Weakness/tiredness general

2.1

28.9

334

1792

H53.1

ICD-10 Finland

Subjective visual disturbances

2.8

28.9

156

596

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

28.7

312

1636

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

3.0

28.3

137

493

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.3

28.3

247

1184

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.4

28.2

218

991

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

28.1

201

882

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

28.0

243

1162

J01DB01

ATC

cefalexin; oral

2.3

27.9

1330

11280

M01AE02

ATC

naproxen; oral, rectal

1.8

27.8

950

7209

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

27.6

170

694

C07AA05

ATC

propranolol; systemic

2.0

27.6

387

2223

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

27.5

535

3424

UKC02

NOMESCO Finland

Cystoscopy

2.3

27.5

233

1103

XF600

NOMESCO Finland

Bloodpressure measurement

2.9

27.3

134

486

R05

ICD-10 Finland

Cough

2.0

27.2

400

2335

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

27.0

434

2608

R50.9

ICD-10 Finland

Fever, unspecified

2.1

27.0

284

1467

Z3231

NOMESCO Finland

Registered nurse

1.9

27.0

459

2811

R06AE07

ATC

cetirizine; oral

1.8

26.9

764

5467

L12

ICPC

Hand/finger symptom/complaint

2.0

26.9

343

1904

N02BF02

ATC

pregabalin; oral

2.7

26.8

153

601

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

26.8

332

1823

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

26.8

271

1378

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.6

26.7

269

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

26.6

320

1738

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.0

26.4

123

433

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

26.2

778

5624

R07.1

ICD-10 Finland

Chest pain on breathing

5.4

26.2

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

26.1

482

3024

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

25.8

701

4933

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.2

25.7

106

348

N06AX16

ATC

venlafaxine; oral

2.1

25.6

285

1501

J01FA06

ATC

roxithromycin; oral

1.8

25.6

658

4554

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

25.6

200

912

G50.1

ICD-10 Finland

Atypical facial pain

4.8

25.6

124

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

25.5

147

580

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

25.5

242

1198

R01AD58

ATC

fluticasone, combinations; nasal

1.9

25.4

453

2806

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.3

25.4

162

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

25.3

255

1293

R55

ICD-10 Finland

Syncope and collapse

2.3

25.2

207

965

H02AB07

ATC

prednisone; oral

2.2

25.2

248

1246

R4110

NOMESCO Finland

Physiotherapy

1.8

25.1

467

2931

K10.3

ICD-10 Finland

Alveolitis of jaws

3.0

25.0

115

402

U07

ICPC

Urine symptom/complaint other

2.5

24.9

174

754

Z2221

NOMESCO Finland

Medical doctor

1.8

24.7

466

2935

T78.4

ICD-10 Finland

Allergy, unspecified

3.1

24.7

108

367

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.5

24.6

169

727

N02BF01

ATC

gabapentin; oral

2.3

24.5

213

1017

F29

ICPC

Eye symptom/complaint other

2.3

24.4

216

1038

R06.4

ICD-10 Finland

Hyperventilation

5.2

24.4

L28

ICPC

Limited function/disability (L)

2.0

24.2

337

1922

K08.80

ICD-10 Finland

Toothache NOS

2.3

24.2

193

888

N05AH04

ATC

quetiapine; oral

2.0

24.1

330

1870

J01FF01

ATC

clindamycin; systemic

1.8

23.8

448

2813

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

23.8

170

744

H01

ICPC

Ear pain/earache

2.1

23.6

244

1247

C10AA05

ATC

atorvastatin; oral

1.7

23.6

620

4292

SPAT1097

SPAT

Recording of ECG

2.1

23.5

245

1256

K01

ICPC

Heart pain

6.1

23.5

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

23.4

301

1667

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

23.4

257

1345

I49.1

ICD-10 Finland

Atrial premature depolarization

3.4

23.3

273

Z01.2

ICD-10 Finland

Dental examination

1.7

23.3

784

5803

N06AB04

ATC

citalopram; systemic

1.9

23.2

359

2117

XKD00

NOMESCO Finland

Uroflowmetry

2.4

23.1

175

786

Z3226

NOMESCO Finland

Physiotherapist

2.0

23.0

312

1760

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.3

22.9

271

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

22.8

254

1334

N06AA09

ATC

amitriptyline; systemic

2.3

22.8

180

823

C08CA01

ATC

amlodipine; oral

1.7

22.7

588

4042

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

22.7

269

1446

M01AH02

ATC

rofecoxib; oral

2.2

22.6

220

1097

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.8

22.6

118

442

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

22.4

183

849

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

22.2

183

852

J02AC01

ATC

fluconazole; systemic

1.7

22.2

681

4894

L15

ICPC

Knee symptom/complaint

1.8

22.1

451

2893

M02AA10

ATC

ketoprofen; topical

2.0

22.0

269

1461

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

21.9

848

6474

H57.1

ICD-10 Finland

Ocular pain

3.0

21.9

332

X58

ICD-10 Finland

Exposure to other specified factors

2.0

21.7

267

1453

M75.8

ICD-10 Finland

Other shoulder lesions

3.0

21.5

341

N03AE01

ATC

clonazepam; systemic

2.8

21.5

114

431

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

21.4

220

1120

PD5AD

NOMESCO Finland

CT of aorta

4.2

21.4

139

M54

ICD-10 Finland

Dorsalgia

2.1

21.3

237

1242

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

21.3

181

853

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

21.3

268

1470

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

21.2

126

504

J01FA09

ATC

clarithromycin; systemic

1.7

21.2

515

3463

K04

ICPC

Palpitations/awareness of heart

2.6

21.2

124

493

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

21.1

193

938

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.3

21.1

179

844

N05BA01

ATC

diazepam; systemic, rectal

2.1

21.0

232

1214

N64.4

ICD-10 Finland

Mastodynia

3.2

20.9

276

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

20.9

368

2251

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.2

20.9

205

1025

R35

ICD-10 Finland

Polyuria

2.6

20.8

122

485

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

20.7

878

6821

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.7

20.6

179

N06AX11

ATC

mirtazapine; oral

1.7

20.5

573

3993

G47.3

ICD-10 Finland

Sleep apnoea

1.8

20.5

347

2095

R60.0

ICD-10 Finland

Localized oedema

2.1

20.5

223

1158

S29

ICPC

Skin symptom/complaint other

1.8

20.5

360

2199

L18

ICPC

Muscle pain

3.0

20.5

328

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.5

20.4

114

SPAT1263

SPAT

Sampling

1.7

20.4

672

4889

A99

ICPC

Disease/condition unspecnature/site

2.1

20.3

203

1022

R4110, ,

SPAT

2.0

20.2

248

1346

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

6.5

20.1

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

20.1

383

2396

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

20.1

341

2060

R03BA05

ATC

fluticasone; inhalant

1.9

20.1

321

1903

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.7

20.1

116

458

N05CF01

ATC

zopiclone; oral

1.7

20.0

513

3489

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

20.0

367

2270

U02

ICPC

Urinary frequency/urgency

1.9

20.0

294

1697

R03BA02

ATC

budesonide; inhalant

1.9

20.0

321

1906

R03DC03

ATC

montelukast; oral

1.9

19.9

304

1776

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

19.6

188

931

EB1VA, ,

NOMESCO Finland

1.9

19.5

312

1849

H92.0

ICD-10 Finland

Otalgia

2.4

19.4

135

582

K02

ICPC

Pressure/tightness of heart

3.9

19.4

154

XF404

NOMESCO Finland

Ambulatory ECG

2.3

19.3

149

674

M89.0

ICD-10 Finland

Algoneurodystrophy

26.4

19.1

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

19.0

219

1160

B01AB05

ATC

enoxaparin; parenteral

1.7

19.0

490

3330

P06

ICPC

Sleep disturbance

2.0

19.0

241

1322

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.7

18.9

109

430

W19

ICD-10 Finland

Unspecified fall

2.2

18.9

181

895

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.7

18.8

104

402

R01AD12

ATC

fluticasone furoate; nasal

1.7

18.7

527

3662

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

18.4

278

1614

M01AC06

ATC

meloxicam; systemic, rectal

1.6

18.3

559

3959

S22.3

ICD-10 Finland

Fracture of rib

2.4

18.3

129

560

F01

ICPC

Eye pain

3.2

18.3

240

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

18.1

175

867

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.7

18.1

495

3409

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

18.0

599

4331

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

18.0

1147

9709

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

17.9

1139

9629

AN1

Coronary angiography

2.2

17.8

160

771

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

17.8

148

691

L14

ICPC

Leg/thigh symptom/complaint

2.2

17.7

159

765

P01

ICPC

Feeling anxious/nervous/tense

1.9

17.7

256

1465

K80

ICPC

Cardiac arrhythmia NOS

2.2

17.7

163

793

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.4

17.6

194

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.7

17.5

352

J01MA12

ATC

levofloxacin; systemic

1.8

17.5

278

1640

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.3

17.5

136

617

A06AD11

ATC

lactulose; oral

1.9

17.4

233

1299

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

17.4

508

3548

L29

ICPC

Musculoskeletal sympt/complt other

2.2

17.3

165

813

D09

ICPC

Nausea

2.5

17.3

111

461

WX892

NOMESCO Finland

Monitored bed care

2.4

17.2

127

562

J01EA01

ATC

trimethoprim; systemic

1.7

17.2

456

3105

J45

ICD-10 Finland

Asthma

2.0

17.2

192

1005

N05BA12

ATC

alprazolam; oral

2.1

17.2

179

913

L08

ICPC

Shoulder symptom/complaint

1.7

17.1

385

2510

R01AD09

ATC

mometasone; nasal

1.6

17.1

730

5581

R30.0

ICD-10 Finland

Dysuria

2.7

16.9

352

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

16.9

178

911

D07AC01

ATC

betamethasone; topical

1.6

16.9

565

4073

S21

ICPC

Skin texture symptom/complaint

1.8

16.8

266

1564

SPAT1260

SPAT

Consultation of another employee

1.8

16.8

287

1728

R96

ICPC

Asthma

2.0

16.8

184

956

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.2

16.6

140

656

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

16.6

243

1395

A29

ICPC

General symptom/complaint other

1.9

16.5

236

1345

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

16.5

140

659

PD5BD

NOMESCO Finland

Extensive CT of aorta

5.0

16.4

R03AC03

ATC

terbutaline; inhalant

1.9

16.4

237

1353

J01DA01

ATC

[U] cefalexin

1.6

16.3

945

7711

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.4

16.3

115

499

R83

ICPC

Respiratory infection other

1.6

16.3

437

2980

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.0

16.2

258

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

16.1

117

514

SPAT1254

SPAT

Administration of medicine

1.8

16.1

252

1476

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

16.1

234

1340

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

4.1

16.0

110

N02AA05

ATC

oxycodone; systemic

1.8

15.9

278

1683

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.5

15.9

104

436

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.2

15.8

208

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

15.8

130

604

J01CA04

ATC

amoxicillin; systemic

1.8

15.8

1282

11318

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

15.7

137

651

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.8

15.7

296

K02.1

ICD-10 Finland

Caries of dentine

1.6

15.7

928

7577

WX002

NOMESCO Finland

Sedation and analgesia

1.8

15.7

295

1825

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.6

15.7

384

I20.00

ICD-10 Finland

Unstable angina

3.5

15.4

160

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

15.4

139

670

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

15.3

127

591

J20

ICD-10 Finland

Acute bronchitis

2.0

15.3

184

987

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

15.2

372

2469

L09

ICPC

Arm symptom/complaint

2.4

15.1

103

440

K07.60

ICD-10 Finland

Snapping jaw

2.4

15.1

112

497

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.6

15.1

355

SFA10

NOMESCO Finland

One-surface restoration

1.5

15.1

866

6997

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.7

15.1

314

R01AD08

ATC

fluticasone; nasal

1.6

15.1

449

3131

A03

ICPC

Fever

1.7

15.1

299

1876

K59.0

ICD-10 Finland

Constipation

2.4

15.1

104

447

ZXE00

NOMESCO Finland

One hour or less

1.6

15.0

586

4350

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

15.0

309

SPAT1312

SPAT

General health counselling

1.6

15.0

495

3537

A97

ICPC

No disease

1.7

14.9

336

2182

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

4.3

14.8

S18

ICPC

Laceration/cut

1.5

14.8

714

5547

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.2

14.7

129

614

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.1

14.7

201

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

14.7

557

4103

A03FA02

ATC

cisapride; oral, rectal

2.2

14.6

128

609

D10

ICPC

Vomiting

2.3

14.6

120

557

Z00.0

ICD-10 Finland

General medical examination

1.7

14.6

316

2030

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

14.5

521

3789

A03CA02

ATC

clidinium and psycholeptics; oral

2.5

14.5

411

M01AX01

ATC

nabumetone; oral

2.7

14.5

286

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

14.4

165

869

N03AX09

ATC

lamotrigine; oral

2.4

14.4

418

KH1AD

NOMESCO Finland

CT of urinary organs

3.0

14.4

214

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

3.0

14.3

226

S80.0

ICD-10 Finland

Contusion of knee

2.1

14.2

145

733

R5599

NOMESCO Finland

Other rehabilitation service

3.0

14.1

206

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

14.1

855

6946

R04.2

ICD-10 Finland

Haemoptysis

3.1

14.0

196

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.5

14.0

380

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

14.0

103

456

C10AX09

ATC

ezetimibe; oral

1.8

14.0

242

1458

SFA20

NOMESCO Finland

Two-surface restoration

1.5

13.9

900

7401

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

13.9

213

1237

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

13.9

450

3191

J01FA10

ATC

azithromycin; systemic

1.5

13.9

906

7465

SPAT1211

SPAT

Application of soft bandage

2.0

13.8

152

790

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.5

13.8

353

SPAT1301

SPAT

No procedures

1.6

13.7

474

3408

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

13.7

670

5194

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.2

13.7

122

585

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

13.7

170

922

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

13.7

342

2277

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.9

13.6

232

N05AX08

ATC

risperidone; systemic

2.1

13.6

143

730

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

13.5

162

867

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.6

13.5

296

B01AC04

ATC

clopidogrel; oral

1.8

13.5

221

1309

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.9

13.5

188

1059

B02.9

ICD-10 Finland

Zoster without complication

2.2

13.5

122

589

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

13.4

105

477

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.4

13.4

407

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

13.4

1396

12782

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

13.4

630

4838

M77.1

ICD-10 Finland

Lateral epicondylitis

2.1

13.3

130

646

A02BA04

ATC

nizatidine; systemic

2.2

13.3

118

565

Z2446

NOMESCO Finland

Social worker

2.2

13.3

119

572

M13.9

ICD-10 Finland

Arthritis, unspecified

2.1

13.2

126

620

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.3

13.2

435

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

13.2

214

1263

M94.9

ICD-10 Finland

Disorder of cartilage, unspecified

40.4

13.2

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

13.1

1048

8951

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.6

13.1

122

M01AX17

ATC

nimesulide; oral

1.6

13.1

347

2339

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

13.1

278

1771

E0000UV, ,

ATC

1.5

13.0

653

5071

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

13.0

375

H02AB04

ATC

methylprednisolone; systemic

1.8

13.0

228

1378

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

13.0

469

3400

Z00.8

ICD-10 Finland

Other general examinations

2.0

12.9

141

730

J01CA08

ATC

pivmecillinam; oral

1.5

12.9

725

5757

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

12.9

370

2542

K74

ICPC

Ischaemic heart dis with angina

5.1

12.9

GD1AA, ,

SPAT

1.7

12.9

265

1673

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

12.8

123

607

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.2

12.8

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

12.8

196

1137

M54.3

ICD-10 Finland

Sciatica

2.3

12.8

103

474

R10.0

ICD-10 Finland

Acute abdomen

2.8

12.7

224

C07AB02

ATC

metoprolol; systemic

1.7

12.7

279

1794

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

12.6

189

1088

SPAT1240

SPAT

Therapeutic discussion

1.9

12.6

182

1036

R03BB04

ATC

tiotropium bromide; inhalant

2.0

12.6

144

758

K58

ICD-10 Finland

Irritable bowel syndrome

2.9

12.6

209

R06AX27

ATC

desloratadine; oral

1.5

12.5

469

3420

SPAT1216

SPAT

Assessment of functional ability

1.7

12.5

231

1415

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

12.5

312

2071

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

12.5

232

1424

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.8

12.5

221

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

12.5

145

768

R52.0

ICD-10 Finland

Acute pain

2.6

12.4

279

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.6

12.4

279

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

12.4

154

834

K85

ICPC

Elevated blood pressure

1.7

12.4

267

1706

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

12.4

126

636

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.0

12.4

134

692

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

12.4

111

534

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

12.3

304

2011

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

12.3

436

K04.1

ICD-10 Finland

Necrosis of pulp

1.9

12.2

177

1008

L19

ICPC

Muscle symptom/complaint NOS

2.8

12.2

224

B01AA03

ATC

warfarin; systemic

1.7

12.2

233

1442

W10

ICD-10 Finland

Fall on and from stairs and steps

2.2

12.1

452

UJD02

NOMESCO Finland

Gastroscopy

2.4

12.1

350

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

12.0

284

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.2

12.0

447

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

11.9

169

956

S70.0

ICD-10 Finland

Contusion of hip

2.5

11.9

291

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

11.9

401

2852

U71

ICPC

Cystitis/urinary infection other

2.0

11.9

137

724

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

11.8

117

584

S69.9

ICD-10 Finland

Unspecified injury of wrist and hand

3.3

11.8

131

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

11.8

147

798

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.2

11.7

152

R06.2

ICD-10 Finland

Wheezing

2.4

11.7

355

R03BA08

ATC

ciclesonide; inhalant

1.9

11.7

147

799

N03AF01

ATC

carbamazepine; oral, rectal

2.3

11.7

374

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

11.7

157

873

EBA00

NOMESCO Finland

Extraction of tooth

1.5

11.7

559

4277

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

11.7

108

526

ZXA00

NOMESCO Finland

Right side

1.6

11.6

376

2648

L13

ICPC

Hip symptom/complaint

1.6

11.6

309

2080

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.7

11.6

230

SPAT1283

SPAT

Restricted health certificate

1.6

11.6

281

1849

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.2

11.6

434

M01AB55

ATC

diclofenac, combinations; oral

2.1

11.6

106

514

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

11.6

441

3219

N05AX12

ATC

aripiprazole; systemic

2.4

11.5

320

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

11.5

345

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

11.5

296

1975

XQ800

NOMESCO Finland

Prick test

2.0

11.5

129

675

R4120

NOMESCO Finland

Occupational therapy

2.1

11.5

109

536

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

11.4

132

697

ZXD05

NOMESCO Finland

Urgent procedure

1.5

11.4

432

3148

N06AB03

ATC

fluoxetine; oral

1.7

11.4

203

1230

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

11.3

333

2293

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

11.3

241

1534

A07AA02

ATC

nystatin; oral

2.2

11.3

100

479

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

11.2

449

3306

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.9

11.2

152

847

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

5.0

11.2

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

11.2

397

2849

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.8

11.2

206

ZXA05

NOMESCO Finland

Left side

1.6

11.1

340

2361

C03CA01

ATC

furosemide; systemic

1.5

11.1

400

2879

SPAT1104

SPAT

Monitoring of emergency patient

2.2

11.1

469

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

11.0

125

656

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

11.0

185

A02BX02

ATC

sucralfate; oral

2.5

11.0

266

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

11.0

202

1234

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

11.0

127

671

N41.1

ICD-10 Finland

Chronic prostatitis

3.7

11.0

N76.0

ICD-10 Finland

Acute vaginitis

2.0

11.0

125

657

K24

ICPC

Fear of heart disease

2.8

11.0

191

L16

ICPC

Ankle symptom/complaint

1.7

11.0

207

1274

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

10.9

173

1012

D19

ICPC

Teeth/gum symptom/complaint

1.5

10.9

487

3666

T74.1

ICD-10 Finland

Physical abuse

3.4

10.9

113

A28

ICPC

Limited function/disability NOS

1.6

10.8

263

1729

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

10.8

119

618

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

10.8

359

2539

G54.0

ICD-10 Finland

Brachial plexus disorders

2.8

10.8

193

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

10.7

226

1433

Z01.7

ICD-10 Finland

Laboratory examination

1.6

10.7

270

1791

SFA30

NOMESCO Finland

Three-surface restoration

1.4

10.7

615

4852

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

10.7

344

2415

R5110, ,

SPAT

1.9

10.7

143

794

R06AX22

ATC

ebastine; oral

1.6

10.7

267

1768

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

10.7

158

906

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.8

10.7

165

959

N06AB06

ATC

sertraline; oral

1.7

10.6

198

1214

I20.01

ICD-10 Finland

Unstable angina

3.2

10.6

135

K04.7

ICD-10 Finland

Periapical abscess without sinus

2.2

10.6

430

SGA01

NOMESCO Finland

Emergency treatment

1.6

10.6

248

1615

UJF92

NOMESCO Finland

Capsular endoscopy

3.2

10.6

130

SXC05

NOMESCO Finland

Other oral or dental procedure

2.0

10.6

113

581

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.4

10.6

296

R25.2

ICD-10 Finland

Cramp and spasm

3.0

10.6

162

M35.7

ICD-10 Finland

Hypermobility syndrome

3.7

10.5

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

10.5

383

2761

P76

ICPC

Depressive disorder

2.0

10.4

123

655

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.8

10.4

176

1050

H53.2

ICD-10 Finland

Diplopia

2.6

10.4

226

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.8

10.4

186

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

3.6

10.3

R29

ICPC

Respiratory symptom/complaint other

2.0

10.3

118

621

M54.1

ICD-10 Finland

Radiculopathy

2.4

10.3

287

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

10.3

281

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

2.1

10.3

449

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

4.4

10.3

P29

ICPC

Psychological sympt/compl other

1.9

10.3

138

767

C09CA06

ATC

candesartan; oral

1.5

10.2

357

2549

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.9

10.2

123

660

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

10.2

524

4042

J05AB11

ATC

valaciclovir; oral

1.6

10.2

233

1509

R33

ICD-10 Finland

Retention of urine

2.1

10.1

438

C09AA05

ATC

ramipril; oral

1.5

10.1

325

2280

L84

ICPC

Back syndrome without radiat pain

2.1

10.0

433

SDA03

NOMESCO Finland

Periodontal treatment

1.4

10.0

613

4874

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

10.0

488

U05

ICPC

Urination problems other

2.2

10.0

394

S92.5

ICD-10 Finland

Fracture of other toe

2.7

10.0

207

D29

ICPC

Digestive symptom/complaint other

2.8

10.0

173

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

9.9

175

1056

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

9.9

202

R31

ICD-10 Finland

Unspecified haematuria

1.9

9.9

119

638

JAH01

NOMESCO Finland

Laparoscopy

2.3

9.9

350

K11.2

ICD-10 Finland

Sialoadenitis

2.6

9.9

214

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.4

9.8

287

K04.08

ICD-10 Finland

Other specified pulpit

1.9

9.8

130

719

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.5

9.8

257

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

9.7

599

4762

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

9.7

575

4539

L50.9

ICD-10 Finland

Urticaria, unspecified

2.3

9.7

314

S10

ICPC

Boil/carbuncle

2.1

9.7

487

C09CA01

ATC

losartan; oral

1.5

9.7

346

2479

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

9.7

176

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

9.6

440

K03.66

ICD-10 Finland

Tooth plaque

1.9

9.6

127

702

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.8

9.5

166

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

9.5

108

567

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

9.5

248

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.3

9.5

336

WX290

NOMESCO Finland

Other blockage of nerve

1.4

9.5

724

5964

A07AA09

ATC

vancomycin; oral

3.8

9.5

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.3

9.5

330

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

9.5

132

742

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

9.5

116

626

N20.9

ICD-10 Finland

Urinary calculus, unspecified

3.1

9.4

129

S33.5

ICD-10 Finland

Sprain and strain of lumbar spine

3.9

9.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

9.4

195

1229

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

9.4

121

663

A01AB09

ATC

miconazole; local oral

1.8

9.4

136

774

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.0

9.4

107

563

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

9.4

486

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

9.4

418

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.7

9.3

185

SPAT1252

SPAT

Overall medication plan or its review

2.0

9.3

101

522

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

9.3

146

D07AD01

ATC

clobetasol; topical

1.6

9.3

246

1648

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.1

9.3

125

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

9.2

107

566

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

9.2

289

N89

ICPC

Migraine

2.2

9.2

360

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

2.4

9.2

264

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

9.2

440

3332

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.7

9.2

175

P74

ICPC

Anxiety disorder/anxiety state

2.0

9.2

469

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

9.2

305

2149

SPAT1310

SPAT

Counselling related to known health issue

1.4

9.2

464

3552

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

9.2

221

1447

C10AC01

ATC

colestyramine; oral

2.7

9.2

187

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

9.2

126

706

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

9.1

157

940

WX402

NOMESCO Finland

General anaesthesia

1.5

9.1

324

2314

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.3

9.1

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

9.1

104

548

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.8

9.1

R09

ICPC

Sinus symptom/complaint

1.8

9.1

149

881

XKC03

NOMESCO Finland

Water cystometry

2.7

9.1

188

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.3

9.1

298

A13

ICPC

Concern/fear medical treatment

2.9

9.1

143

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.7

9.0

185

1162

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.4

9.0

273

H81.3

ICD-10 Finland

Other peripheral vertigo

2.6

9.0

200

N03AG01

ATC

valproic acid; systemic, rectal

2.0

9.0

472

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.5

9.0

236

M77.4

ICD-10 Finland

Metatarsalgia

1.9

9.0

107

571

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

9.0

132

754

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

9.0

344

G43.3

ICD-10 Finland

Complicated migraine

2.9

9.0

138

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.1

9.0

122

C08DA01

ATC

verapamil; systemic

2.2

9.0

338

A92

ICPC

Allergy/allergic reaction NOS

2.4

9.0

274

C10AA01

ATC

simvastatin; oral

1.4

9.0

515

4031

K84

ICPC

Heart disease other

2.8

9.0

155

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.9

8.9

144

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.2

8.9

107

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

8.9

505

3942

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

8.9

U01

ICPC

Dysuria/painful urination

1.8

8.9

148

878

J05AB01

ATC

aciclovir; systemic

1.5

8.9

339

2456

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

8.9

101

531

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

8.9

232

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

8.9

994

8694

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

8.9

400

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

8.8

264

1817

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

4.7

8.8

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.7

8.8

179

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.6

8.8

185

A06AC51

ATC

ispaghula, combinations; oral

2.1

8.8

374

K58.8

ICD-10 Finland

Other and unspecified irritable bowel syndrome

8.7

8.8

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.5

8.8

233

R25.1

ICD-10 Finland

Tremor, unspecified

2.5

8.8

209

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

8.8

174

1084

-69

ICPC

Other reason for encounter NEC

2.3

8.8

277

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.0

8.8

101

534

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

8.7

175

1094

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.6

8.7

204

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.8

8.7

123

696

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

8.7

135

786

L20

ICPC

Joint symptom/complaint NOS

2.2

8.7

317

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

8.6

132

764

A27

ICPC

Fear of other disease NOS

2.1

8.6

411

K29.7

ICD-10 Finland

Gastritis, unspecified

2.4

8.6

254

R03BA01

ATC

beclometasone; inhalant

1.6

8.6

204

1331

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

8.6

120

676

S20.2

ICD-10 Finland

Contusion of thorax

2.1

8.6

378

H29

ICPC

Ear symptom/complaint other

1.6

8.5

186

1187

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

8.5

399

G57.1

ICD-10 Finland

Meralgia paraesthetica

3.5

8.5

P99

ICPC

Psychological disorders other

2.4

8.5

243

SPAT1058

SPAT

PEF monitoring instruction

1.8

8.5

120

678

S29.9

ICD-10 Finland

Unspecified injury of thorax

6.4

8.5

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

8.5

281

WVA20

NOMESCO Finland

Medicine administration

2.6

8.5

189

R75

ICPC

Sinusitis acute/chronic

2.0

8.4

456

PA6AD

NOMESCO Finland

CT of neck arteries

2.3

8.4

263

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

8.4

188

1208

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

8.4

148

893

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

3.5

8.4

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

8.4

226

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

8.4

248

1702

C08CA07

ATC

nisoldipine; oral

4.5

8.4

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.7

8.4

161

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.9

8.4

103

557

SPAT1229

SPAT

Assessment of need for aid

1.9

8.3

106

579

K05.18

ICD-10 Finland

Chronic gingivitis

1.8

8.3

120

682

M75

ICD-10 Finland

Shoulder lesions

2.2

8.3

342

Z50.1

ICD-10 Finland

Other physical therapy

2.1

8.3

396

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.4

8.3

233

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

8.3

290

79199

ICD-8 Finland

Headache

3.7

8.3

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

8.3

494

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

8.3

144

865

R20.0

ICD-10 Finland

Anaesthesia of skin

4.1

8.3

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

8.3

120

684

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

3.6

8.3

C05AA08

ATC

fluocortolone; rectal, topical

1.6

8.3

183

1173

D12

ICPC

Constipation

2.3

8.3

278

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

8.2

114

640

K92.1

ICD-10 Finland

Melaena

2.1

8.2

357

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

8.2

146

883

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

4.2

8.2

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

8.2

140

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.1

8.2

358

S50.1

ICD-10 Finland

Contusion of other and unspecified parts of forearm

3.6

8.1

C10AA03

ATC

pravastatin; oral

1.9

8.1

526

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.7

8.1

152

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

8.1

400

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.0

8.1

477

N05AH03

ATC

olanzapine; systemic

1.9

8.1

103

563

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.4

8.1

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.4

8.1

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

8.1

175

1115

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

8.1

321

2341

S23.4

ICD-10 Finland

Sprain and strain of ribs and sternum

3.0

8.1

114

F41.00

ICD-10 Finland

Moderate panic disorder

3.0

8.1

114

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.3

8.1

268

C10AA07

ATC

rosuvastatin; oral

1.4

8.1

442

3420

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.2

8.0

327

N29

ICPC

Neurological sympt/complt other

2.9

8.0

125

L11

ICPC

Wrist symptom/complaint

1.7

8.0

157

974

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

8.0

311

2256

KMAK, ,

NOMESCO Finland

1.4

8.0

741

6240

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.2

8.0

N06AX03

ATC

mianserin; oral

2.1

8.0

362

E66.8

ICD-10 Finland

Other obesity

2.0

8.0

480

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

7.9

390

D16

ICPC

Rectal bleeding

2.7

7.9

160

N05AA02

ATC

levomepromazine; systemic

2.3

7.9

277

J01

ICD-10 Finland

Acute sinusitis

1.9

7.9

503

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.1

7.9

105

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

7.9

139

839

H03AA01

ATC

levothyroxine sodium; systemic

1.4

7.9

361

2704

F43.00

ICD-10 Finland

Acute stress reaction mild

2.5

7.9

190

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

7.9

137

824

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

7.9

405

Z01.9

ICD-10 Finland

Special examination, unspecified

1.9

7.9

518

N05CD07

ATC

temazepam; oral

1.7

7.8

156

973

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.3

7.8

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

7.8

150

927

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.8

7.8

133

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

7.0

7.8

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

7.8

174

1118

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.1

7.8

106

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

7.8

412

3167

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.7

7.7

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

7.7

319

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

4.4

7.7

M48.0

ICD-10 Finland

Spinal stenosis

1.6

7.7

171

1097

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

7.7

561

4544

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.5

7.7

G04CA02

ATC

tamsulosin; oral

1.6

7.7

184

1203

L60.0

ICD-10 Finland

Ingrowing nail

2.0

7.7

423

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

7.6

523

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

7.6

516

G43

ICD-10 Finland

Migraine

1.9

7.6

509

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

7.6

250

1753

G03DC03

ATC

lynestrenol; oral

2.7

7.6

152

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

7.6

143

879

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

7.6

446

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.9

7.6

124

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.2

7.6

N06AX26

ATC

vortioxetine; oral

1.8

7.6

120

703

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

7.6

197

1313

U72

ICPC

Urethritis

2.5

7.5

194

B01AF02

ATC

apixaban; oral

1.6

7.5

177

1151

N06AB10

ATC

escitalopram; oral

1.5

7.5

310

2274

TAB00

NOMESCO Finland

Lumbar puncture

2.1

7.5

357

SAA01, ,

SPAT

4.3

7.5

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

7.5

159

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

7.5

448

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

7.5

226

JN3AE, ,

SPAT

2.1

7.4

324

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.9

7.4

528

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.8

7.4

115

670

RF210, ,

NOMESCO Finland

2.5

7.4

190

K05.09

ICD-10 Finland

Acute gingivitis, UNS

3.0

7.4

104

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.0

7.4

104

NA2AA, ,

SPAT

4.0

7.4

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.2

7.4

266

S50.0

ICD-10 Finland

Contusion of elbow

2.3

7.3

234

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.3

7.3

234

A91

ICPC

Abnormal result investigation NOS

1.9

7.3

480

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.5

7.3

179

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.7

7.3

138

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

7.3

128

772

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

7.3

337

2525

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

7.3

130

788

ZX120

NOMESCO Finland

Intravenous

1.7

7.3

130

788

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

3.3

7.3

N30

ICD-10 Finland

Cystitis

1.7

7.2

142

882

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

7.2

519

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.6

7.2

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

7.2

462

S01

ICPC

Pain/tenderness of skin

2.0

7.1

364

R04.0

ICD-10 Finland

Epistaxis

1.8

7.1

103

587

P01BA02

ATC

hydroxychloroquine; oral

1.7

7.1

124

746

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

7.1

406

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

7.1

257

J03.0

ICD-10 Finland

Streptococcal tonsillitis

2.1

7.1

290

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

7.1

391

3019

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

7.1

215

1482

N05AE04

ATC

ziprasidone; systemic

5.6

7.1

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

7.1

393

ZY010

NOMESCO Finland

Hospital outpatient

1.9

7.1

457

A05

ICPC

Feeling ill

1.8

7.0

109

634

S04

ICPC

Lump/swelling localized

1.6

7.0

173

1137

C01CA24

ATC

epinephrine; parenteral

1.8

7.0

103

590

N80.0

ICD-10 Finland

Endometriosis of uterus

2.7

7.0

141

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.0

7.0

102

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.6

7.0

160

1034

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

7.0

189

N06AX05

ATC

trazodone; oral

2.5

7.0

177

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

6.9

118

705

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

6.9

106

614

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

6.9

221

S16

ICPC

Bruise/contusion

2.3

6.9

215

M77.0

ICD-10 Finland

Medial epicondylitis

2.5

6.9

172

SPAT1251

SPAT

Organisation of medication

2.2

6.9

241

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.2

6.9

K22.7

ICD-10 Finland

Barrett oesophagus

3.5

6.9

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.4

6.8

L72.1

ICD-10 Finland

Trichilemmal cyst

1.8

6.8

102

587

G57.6

ICD-10 Finland

Lesion of plantar nerve

2.7

6.8

137

G44.8

ICD-10 Finland

Other specified headache syndromes

3.0

6.8

SPAT1281

SPAT

Other administrative function

1.7

6.8

112

663

M05BA04

ATC

alendronic acid; oral

1.7

6.8

131

810

R06

ICPC

Nose bleed/epistaxis

2.6

6.8

149

-1, ,

NOMESCO Finland

1.4

6.8

491

3954

S99.9

ICD-10 Finland

Unspecified injury of ankle and foot

2.5

6.8

173

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

6.8

329

M75.5

ICD-10 Finland

Bursitis of shoulder

2.5

6.8

167

NG1AA, ,

SPAT

1.7

6.8

117

702

N05CF02

ATC

zolpidem; oral

1.5

6.8

253

1818

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

6.8

399

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

4.3

6.8

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.1

6.8

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

3.1

6.8

M23.8

ICD-10 Finland

Other internal derangements of knee

2.2

6.7

256

R2110

NOMESCO Finland

Giving the first information

1.8

6.7

552

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

6.7

428

R07

ICPC

Sneezing/nasal congestion

1.7

6.7

110

650

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

6.7

337

XG460

NOMESCO Finland

Short time oxymetry

3.2

6.7

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.1

6.7

290

B34.9

ICD-10 Finland

Viral infection, unspecified

2.3

6.7

218

D07AB08

ATC

desonide; topical

1.6

6.7

156

1013

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

6.7

311

WZC00, ,

SPAT

1.5

6.7

222

1560

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.6

6.6

145

M01AH03

ATC

valdecoxib; oral

1.9

6.6

438

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.2

6.6

245

TND32

NOMESCO Finland

Custom moulded splint, wrist or hand

3.1

6.6

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

6.6

417

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.6

6.6

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.2

6.6

239

J01DA08

ATC

[U] cefaclor

1.6

6.5

167

1107

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

6.5

286

N63

ICD-10 Finland

Unspecified lump in breast

1.7

6.5

114

687

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

6.5

120

734

N03AF02

ATC

oxcarbazepine; oral

2.2

6.5

234

SPAT1153

SPAT

Removal of sutures

1.4

6.5

408

3212

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.6

6.5

135

XF400, ,

SPAT

3.7

6.5

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.8

6.5

485

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

5.7

6.5

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

6.5

162

1070

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

3.2

6.5

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.9

6.4

R4190

NOMESCO Finland

Nutritional therapy

2.1

6.4

268

S02

ICPC

Pruritus

2.0

6.4

309

K03.80

ICD-10 Finland

Irradiated enamel

1.8

6.4

524

K57

ICD-10 Finland

Diverticular disease of intestine

2.6

6.4

136

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

6.4

303

2275

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

6.4

166

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.9

6.4

102

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

6.4

289

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.0

6.4

358

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

6.4

577

T75.4

ICD-10 Finland

Effects of electric current

4.1

6.4

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.1

6.4

C08CA02

ATC

felodipine; oral

1.7

6.4

118

723

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.0

6.3

310

D73

ICPC

Gastroenteritis presumed infection

2.1

6.3

263

L03

ICD-10 Finland

Cellulitis

3.6

6.3

C07AA07

ATC

sotalol; systemic

2.3

6.3

211

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.6

6.3

137

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.2

6.3

237

H60

ICD-10 Finland

Otitis externa

1.8

6.3

460

H65.0

ICD-10 Finland

Acute serous otitis media

2.8

6.3

114

SPAT1360

SPAT

Extensive global examination

1.8

6.3

505

J01MA06

ATC

norfloxacin; oral

1.5

6.3

185

1267

K04.00

ICD-10 Finland

Hyperemia of pulp

1.9

6.3

403

K04.0

ICD-10 Finland

Pulpitis

1.6

6.3

135

860

R01

ICPC

Pain respiratory system

2.7

6.2

126

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.0

6.2

T82

ICPC

Obesity

2.0

6.2

347

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.6

6.2

132

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.9

6.2

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

6.2

462

K29

ICPC

Cardiovascular sympt/complt other

2.1

6.2

292

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

6.2

552

4570

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.7

6.2

L10

ICPC

Elbow symptom/complaint

1.9

6.2

419

C08CA05

ATC

nifedipine; systemic

1.9

6.2

391

F03

ICPC

Eye discharge

1.7

6.2

107

644

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.2

6.1

220

TNX00, ,

SPAT

3.0

6.1

S12

ICPC

Insect bite/sting

1.6

6.1

129

817

X15

ICPC

Vaginal symptom/complaint other

1.9

6.1

392

R68.2

ICD-10 Finland

Dry mouth, unspecified

4.1

6.1

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.7

6.1

122

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.7

6.1

122

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

6.1

190

1317

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.1

6.1

254

N03AX11

ATC

topiramate; oral

2.3

6.1

189

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

6.1

261

N04BC05

ATC

pramipexole; oral

1.7

6.1

107

647

R01AD59

ATC

mometasone, combinations; nasal

1.7

6.1

104

624

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

6.0

109

663

Angiography of the heart and coronary arteries

1.9

6.0

351

P20

ICPC

Memory disturbance

1.5

6.0

176

1203

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

6.0

373

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

618

2605

3.28

107.26

7.3

3.8

84.28

350.74

ng/l

4.85

434

1918

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

930

5016

3.13

104.01

6.6

3.6

29.00

54.51

ng/l

0.81

584

3350

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

676

3211

2.96

92.24

2.5

1.7

0.67

1.11

mg/l

11.06

519

2449

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1119

7165

3.01

83.66

7.2

6.2

10.44

11.00

umol/l

0.62

1089

6823

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

803

4355

2.75

82.62

3.6

2.5

57.97

60.88

u/l

0.33

756

4025

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

737

4184

2.45

64.04

3.0

2.2

132.82

199.86

u/l

2.75

704

3970

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

337

1367

2.87

57.79

3.9

2.3

30.27

39.13

u/l

3.05

300

1145

(3032080) INR in Blood by Coagulation assay

915

5936

2.32

55.80

17.7

13.6

1.21

1.22

inr

0.20

790

4930

(3013826) Glucose [Moles/volume] in Serum or Plasma

1124

7973

2.49

55.65

6.5

4.9

6.33

6.59

mmol/l

6.20

1091

7493

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1344

10409

3.17

55.58

10.7

7.9

78.17

77.94

u/l

0.06

1300

9869

(3002582) Erythrocytes [#/volume] in Urine

739

4408

2.29

54.81

5.0

3.3

20.58

64.59

e6/l

2.13

571

3338

(3022096) Basophils/Leukocytes in Blood

974

6578

2.29

52.66

7.9

6.3

0.66

0.68

0.83

926

6164

(3006504) Eosinophils/Leukocytes in Blood

975

6588

2.29

52.65

7.8

6.3

2.70

2.77

0.49

931

6184

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1316

10194

2.91

52.04

6.3

4.4

11.89

11.93

mm/h

0.04

1262

9550

(3019069) Monocytes/Leukocytes in Blood

973

6602

2.27

51.52

7.9

6.4

8.70

8.65

0.20

927

6207

(3006315) Basophils [#/volume] in Blood

1025

7152

2.28

50.02

7.8

6.2

0.04

e9/l

0.72

907

6182

(3018010) Neutrophils/Leukocytes in Blood

973

6656

2.24

49.73

7.7

6.2

56.63

57.15

0.78

940

6367

(3019198) Lymphocytes [#/volume] in Blood

1038

7304

2.27

49.26

7.8

6.2

2.01

1.94

e9/l

0.49

941

6462

(3002030) Lymphocytes/Leukocytes in Blood

983

6769

2.23

49.18

7.8

6.3

28.38

28.10

0.37

945

6438

(3001604) Monocytes [#/volume] in Blood

1021

7144

2.25

49.02

7.9

6.2

0.58

0.57

e9/l

0.57

906

6177

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

993

6889

2.23

48.43

7.4

6.9

1.22

mmol/l

0.60

893

5977

(3030467) Casts [#/volume] in Urine by Automated count

649

3814

2.21

48.25

4.7

3.2

0.30

0.41

e6/l

1.15

472

2768

(3018095) Leukocytes [#/volume] in Urine

803

5184

2.14

46.33

6.0

3.9

55.36

100.88

e6/l

2.10

594

3539

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

754

4753

2.14

46.29

3.6

3.1

34.84

31.29

u/l

0.53

710

4501

(3013115) Eosinophils [#/volume] in Blood

1035

7383

2.21

45.89

8.3

6.4

0.18

0.19

e9/l

0.23

937

6469

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

648

3881

2.15

45.15

3.4

3.1

1031.97

1124.16

ng/l

0.26

535

3293

(3013650) Neutrophils [#/volume] in Blood by Automated count

1098

8060

2.24

44.70

10.9

9.3

4.14

4.07

e9/l

0.50

976

7052

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

426

2169

2.33

44.17

4.2

3.0

3.80

3.61

e6/l

0.12

212

1006

(42870588) Differential panel, method unspecified - Blood

738

4683

2.10

43.77

7.4

6.1

—

(3000850) Epithelial cells [#/volume] in Urine

541

3057

2.18

43.38

3.5

2.6

7.37

7.20

e6/l

0.08

498

2789

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

339

1583

2.46

42.56

3.0

2.6

6.66

7.24

umol/l

0.22

287

1377

(3031040) Bacteria [#/volume] in Urine by Automated count

1199

9241

2.31

41.53

8.2

4.8

225.07

2560.32

e6/l

2.71

131

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

890

6130

2.06

41.38

6.6

6.2

1.22

mmol/l

0.17

838

5663

(3048689) Calprotectin [Mass/mass] in Stool

389

1963

2.31

40.76

2.6

2.4

107.30

115.98

ug/g

0.29

322

1573

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

499

2792

2.16

40.52

1.5

1.3

35.06

29.35

iu/ml

0.24

132

861

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

436

2356

2.18

38.35

4.3

2.8

1.00

1.32

e6/l

0.58

222

1194

(3026782) Osmolality of Urine

473

2640

2.14

38.29

3.5

2.8

530.77

519.62

mosm/kgh2o

0.54

422

2323

(3033658) Prothrombin time (PT) actual/Normal

574

3474

2.04

37.14

5.5

3.9

90.41

92.14

0.88

564

3390

(3024561) Albumin [Mass/volume] in Serum or Plasma

866

6101

1.95

35.53

5.0

4.8

36.19

35.95

g/l

0.73

823

5734

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

416

2266

2.14

35.46

2.4

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

455

2585

2.08

34.56

1.5

1.3

11.96

11.88

u/ml

0.01

157

997

(40768797) Stomach Pathology biopsy report

369

1959

2.16

33.34

1.4

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

378

2053

2.11

32.04

1.5

1.4

565.95

531.92

titre

0.09

443

(3007164) IgA [Mass/volume] in Serum or Plasma

509

3078

1.97

32.03

1.7

1.5

2.25

2.32

g/l

0.38

287

1916

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1161

9250

2.01

30.80

4.6

3.2

47.36

44.03

u/l

0.47

1107

8737

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

850

6139

1.85

30.35

2.4

2.1

97.21

97.17

pmol/l

0.01

453

3195

(3023368) Bacteria identified in Blood by Culture

562

3585

1.89

29.65

5.4

4.1

—

(3018418) pH of Serum or Plasma

632

4192

1.86

29.42

4.4

4.0

7.40

0.42

467

2994

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

477

2897

1.93

29.13

2.1

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

988

7539

1.85

28.91

5.1

4.0

13.55

4.04

estimate

0.48

215

1588

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

321

1702

2.12

28.64

2.4

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

664

4512

1.82

28.27

2.8

2.3

—

(3009261) Glucose [Presence] in Urine by Test strip

988

7597

1.83

27.54

5.2

4.0

0.00

0.21

estimate

0.54

207

1506

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

890

6636

1.80

27.46

2.9

2.5

73.92

77.25

nmol/l

3.29

806

6048

(40758558) Short blood count panel - Blood

631

4257

1.81

27.24

7.1

6.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

972

7457

1.81

27.07

5.1

4.0

0.00

estimate

0.50

206

1549

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

220

1025

2.34

26.87

3.4

2.4

5.59

7.07

ug/l

0.63

191

907

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

551

3585

1.83

26.67

1.5

1.3

1.16

1.65

u/ml

0.67

147

981

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

188

820

2.47

26.59

2.2

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1116

8955

1.88

26.57

4.2

3.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

242

1190

2.22

25.95

6.1

7.3

1.38

1.31

mmol/l

0.46

237

1168

(3021589) Normoblasts [#/volume] in Blood

832

6176

1.75

25.16

14.2

10.9

0.00

e9/l

0.02

681

5069

(3026008) Bacteria identified in Urine by Culture

664

4627

1.76

25.09

4.5

3.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

207

970

2.31

24.86

2.6

2.5

30.30

21.43

au/ml

0.67

105

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

194

885

2.36

24.78

1.4

1.3

56.92

39.21

au/ml

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1300

11068

2.08

24.77

6.0

4.6

14.66

14.72

pmol/l

0.37

1220

10240

(3026493) Urate [Moles/volume] in Serum or Plasma

519

3380

1.80

24.62

2.5

2.6

324.12

331.88

umol/l

1.05

446

3013

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

565

3774

1.78

24.60

2.8

2.3

2.64

2.79

mg/l

0.89

483

3256

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1482

13397

3.36

23.94

29.4

15.0

17.05

22.55

mg/l

14.83

1356

11036

(3015736) pH of Urine

813

6048

1.72

23.93

4.3

3.5

6.22

6.25

0.29

450

3381

(3012095) Magnesium [Moles/volume] in Serum or Plasma

376

2240

1.90

23.59

3.6

3.2

0.82

mmol/l

0.16

348

2123

(3025941) Bacteria identified in Stool by Culture

171

758

2.41

23.25

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

917

7092

1.72

23.04

3.6

3.1

103.36

102.88

ug/l

0.02

845

6652

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1433

12784

2.58

22.78

24.8

14.4

84.58

82.98

ml/min/173m2

2.07

1366

11777

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

292

1623

1.98

22.40

2.4

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

596

4146

1.71

21.83

3.6

3.1

0.89

0.02

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

341

2017

1.89

21.66

2.0

29.80

29.18

1.19

333

1956

(40768804) Tissue Pathology biopsy report

750

5556

1.68

21.61

2.3

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

851

6520

1.68

21.51

3.2

2.7

—

estimate

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1424

12745

2.42

21.08

7.7

5.7

1.79

1.88

mu/l

2.57

1354

11929

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

507

3404

1.73

20.94

2.8

2.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

573

3988

1.69

20.67

1.9

1.7

21.34

20.71

nmol/l

0.16

497

3391

(3019550) Sodium [Moles/volume] in Serum or Plasma

1479

13504

3.02

20.50

30.0

17.4

139.56

139.62

mmol/l

0.39

1472

13239

(3015377) Calcium [Moles/volume] in Serum or Plasma

678

4960

1.65

20.01

3.4

2.36

mmol/l

0.16

626

4522

(3023103) Potassium [Moles/volume] in Serum or Plasma

1479

13526

2.99

20.00

30.4

17.6

3.94

3.95

mmol/l

0.89

1470

13237

(3013139) Helicobacter pylori Ag [Presence] in Stool

199

1005

2.12

19.69

1.3

1.2

—

(3013512) EKG study

625

4508

1.65

19.31

5.3

3.5

—

0.79

—

(3000991) Gas panel - Venous blood

217

1145

2.04

19.07

7.4

8.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

347

2138

1.80

19.06

2.3

2.5

2.40

2.36

g/l

0.67

314

1977

(36660697) Celiac disease serology panel - Serum

230

1240

2.00

19.04

1.2

—

(3002032) Base excess in Venous blood by calculation

238

1303

1.98

18.84

3.7

3.3

1.66

1.85

mmol/l

0.37

215

1126

(3012544) pH of Venous blood

242

1337

1.96

18.65

3.7

3.4

7.38

0.04

118

758

(3021447) Carbon dioxide [Partial pressure] in Venous blood

244

1353

1.95

18.60

3.8

3.3

5.84

5.80

kpa

0.24

239

1311

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

192

978

2.10

18.53

2.0

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

123

531

2.43

17.65

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

318

1953

1.79

17.50

2.4

2.5

20.45

22.78

2.43

290

1819

(3022948) Iron [Moles/volume] in Serum or Plasma

359

2286

1.74

17.42

2.4

2.5

12.95

13.19

umol/l

0.21

334

2122

(3030981) Hyaline casts [#/volume] in Urine by Automated count

203

1085

2.00

17.13

3.1

2.4

0.55

0.53

e6/l

0.03

191

1030

(3005322) IgE [Units/volume] in Serum or Plasma

195

1036

2.01

16.72

1.5

1.3

154.20

208.62

u/ml

0.71

189

960

(3022145) Colonoscopy Study observation

266

1571

1.84

16.58

1.4

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

105

442

2.48

15.91

1.5

1.7

0.24

g/l

0.22

424

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

145

703

2.17

15.84

1.6

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

367

2.60

15.59

2.7

3.1

1.16

2.18

index

0.95

185

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

121

550

2.30

15.45

1.6

12.79

10.83

u/ml

0.14

123

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1407

12815

2.05

15.29

6.0

4.9

5.85

mmol/l

0.02

1319

11822

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

138

667

2.17

15.18

2.6

2.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

106

458

2.41

15.18

1.6

1.7

1.21

1.20

g/l

0.13

101

437

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

143

713

2.11

14.52

2.6

2.4

1.26

1.21

0.19

143

707

(3005719) IgG [Mass/volume] in Serum or Plasma

197

1103

1.90

14.42

3.3

2.9

10.17

10.68

g/l

1.01

178

1020

(3027945) Reticulocytes/Erythrocytes in Blood

248

1492

1.79

14.41

2.3

2.8

1.78

1.84

0.48

224

1333

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

264

2.81

14.38

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

264

2.81

14.38

1.5

1.3

—

(3045414) Leukocytes [Presence] in Urine

232

1373

1.81

14.23

2.4

2.1

0.00

0.02

estimate

0.78

289

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1367

12392

1.87

14.17

7.3

6.1

38.69

38.82

mmol/mol

0.25

1296

11656

(3036481) Cortisol [Moles/volume] in Serum or Plasma

236

1414

1.79

13.88

1.9

2.1

358.62

385.46

nmol/l

1.45

217

1309

(3015171) Extractable nuclear Ab [Units/volume] in Serum

121

582

2.17

13.47

1.3

1.2

0.21

1.38

u/ml

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

419

2.38

13.45

1.5

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

406

2835

1.59

13.28

3.0

2.8

2.45

mmol/l

0.18

371

2558

(3023420) DNA double strand Ab [Units/volume] in Serum

127

630

2.11

13.06

1.7

1.9

4.63

7.44

iu/ml

1.09

143

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

175

974

1.90

13.01

3.4

3.0

161.13

195.88

ng/l

0.74

158

889

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

153

817

1.97

12.86

1.1

1.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

160

868

1.94

12.84

1.8

1.18

1.43

g/l

1.41

142

801

(3007853) Bacteria identified in Skin by Aerobe culture

260

1637

1.71

12.78

1.6

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

425

2.32

12.59

1.6

1.4

290.86

293.46

ug/g

0.04

246

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

237

1461

1.73

12.56

4.1

4.3

222.68

249.95

u/l

2.50

226

1393

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

236

1459

1.73

12.37

6.5

8.0

5.07

5.11

kpa

0.29

228

1409

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

282

1829

1.66

12.37

2.7

2.1

—

(3019977) pH of Arterial blood

235

1457

1.72

12.18

6.5

8.1

7.42

0.03

116

803

(3027801) Oxygen [Partial pressure] in Arterial blood

235

1459

1.72

12.12

6.5

8.0

12.01

12.31

kpa

0.42

226

1412

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1495

14119

2.60

12.06

33.2

19.3

73.10

73.41

umol/l

0.19

1489

13969

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

300

1997

1.62

11.82

2.9

2.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

102

3.69

11.81

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

149

3.15

11.46

1.2

1.6

—

(3016502) Oxygen saturation in Arterial blood

210

1286

1.73

11.35

6.7

8.5

95.49

95.51

0.01

204

1246

(3017143) Hepatitis C virus Ab [Presence] in Serum

267

1747

1.64

11.23

1.7

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1487

14053

2.39

11.20

17.5

11.7

26.01

24.99

u/l

1.42

1463

13689

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

118

604

2.03

11.16

1.9

2.1

38.03

39.46

u/l

0.32

102

545

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

189

1129

1.77

11.13

1.3

1.2

118.62

137.97

u/ml

0.24

443

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

702

5656

1.44

10.98

5.0

3.9

0.01

0.13

estimate

0.86

165

1277

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

133

3.22

10.87

1.3

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

147

821

1.87

10.78

3.8

3.4

5.14

5.17

kpa

0.21

142

797

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

331

2.36

10.74

1.2

1.3

3.58

3.73

mmol/l

0.73

313

(3003396) Base excess in Arterial blood by calculation

227

1443

1.67

10.66

6.6

8.0

0.67

1.01

mmol/l

0.60

190

1199

(3019309) Folate [Moles/volume] in Red Blood Cells

328

2281

1.56

10.63

1.8

1.7

1060.27

1182.40

nmol/l

1.55

247

1733

(3048929) Epstein Barr virus Ab [Presence] in Serum

102

505

2.09

10.56

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

181

1088

1.75

10.42

2.5

2.9

66.74

66.93

g/l

0.13

168

1006

(3029937) Albumin [Presence] in Urine by Test strip

533

4110

1.45

10.40

5.3

4.0

0.01

estimate

0.15

204

1478

(3008898) HLA-B27 [Presence]

110

564

2.02

10.37

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

186

1129

1.74

10.34

3.1

3.6

82.43

81.69

ng/l

0.04

174

983

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

435

2.16

10.31

1.4

1.3

12.42

2.56

u/ml

—

(3022621) pH of Urine by Test strip

190

1162

1.72

10.28

3.0

2.6

6.12

6.11

0.07

134

780

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

113

3.33

10.16

1.0

1.1

4.71

9.06

iu/ml

1.04

(3024891) Influenza virus A+B Ag [Presence] in Specimen

398

2.20

10.15

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

438

2.14

10.14

1.4

1.3

10.21

8.81

u/ml

0.08

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

250

1653

1.61

10.01

2.2

1.8

1.42

1.44

0.22

226

1479

(46235355) HIV 1 and 2 tests - Meaningful Use set

410

3027

1.48

9.93

2.1

2.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

443

2.12

9.86

2.5

2.2

362.03

326.70

ug/l

0.12

412

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

161

953

1.77

9.76

3.0

3.4

4.56

4.50

pmol/l

0.23

137

845

(3041096) Erythrocytes [Presence] in Urine by Automated

532

4139

1.43

9.76

4.4

3.3

0.01

0.28

estimate

0.75

171

1258

(3044290) Cell count panel - Cerebral spinal fluid

290

2.37

9.62

1.2

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

110

582

1.96

9.50

2.0

1.5

0.33

0.31

mg/l

0.12

254

(3009343) pH of Capillary blood

140

802

1.82

9.47

3.8

3.5

7.41

7.42

0.38

121

681

(3045424) Erythrocytes [Presence] in Urine

125

691

1.88

9.47

2.2

0.02

0.00

estimate

0.36

219

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.99

9.34

1.1

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

463

2.05

9.14

2.1

1.8

—

(3019150) Specific gravity of Urine by Refractometry

438

3327

1.44

9.01

4.8

4.1

1.02

1.48

kg/l

0.50

318

2198

(3023520) Reticulocytes [#/volume] in Blood

181

1133

1.68

8.97

2.2

2.7

73.80

71.46

e9/l

0.38

130

827

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

358

2.18

8.97

1.4

1.2

47.21

52.59

u/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

446

2.06

8.95

1.4

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

125

704

1.84

8.94

3.4

1.41

1.80

mmol/l

0.42

100

527

(3002173) Hemoglobin [Mass/volume] in Arterial blood

191

1216

1.65

8.86

7.2

8.9

124.30

120.09

g/l

2.33

186

1190

(3028707) Methadone [Presence] in Urine by Screen method

289

2.30

8.81

4.0

2.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

141

828

1.77

8.79

8.7

9.6

93.55

93.77

0.13

141

823

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

227

2.48

8.78

1.3

1.2

1.53

3.44

u/ml

1.52

(3003458) Phosphate [Moles/volume] in Serum or Plasma

258

1769

1.55

8.78

5.0

5.4

1.04

1.03

mmol/l

0.07

237

1632

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

506

1.98

8.74

2.2

1.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

404

2.09

8.64

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1416

13304

1.73

8.63

6.7

5.5

2.71

2.74

mmol/l

0.44

1331

12440

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1341

12435

1.58

8.56

4.9

4.1

1.33

1.26

mmol/l

3.18

1255

11496

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

320

2.21

8.47

1.4

1.6

217.55

435.71

e6/l

0.39

249

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1400

13126

1.68

8.44

5.9

4.9

4.61

4.69

mmol/l

1.96

1324

12312

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

165

1024

1.68

8.44

1.6

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.78

8.36

1.1

—

(40761511) CBC panel - Blood by Automated count

1456

13815

1.87

8.25

21.5

13.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

176

1118

1.65

8.23

6.3

7.0

8.69

9.15

mmol/l

0.36

167

1073

(3036489) Thrombin time

510

1.94

8.21

1.9

2.0

20.93

20.55

0.31

450

(40760892) CBC W Ordered Manual Differential panel - Blood

423

3243

1.42

8.14

5.3

4.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

407

2.04

8.11

1.1

1.2

44.00

90.93

titre

—

(4024509) Urine culture

120

689

1.80

8.07

2.5

2.0

—

(3017732) Neutrophils [#/volume] in Blood

254

1771

1.52

7.96

3.0

3.1

4.36

4.97

e9/l

0.82

208

1546

(3014765) Yersinia sp identified in Stool by Organism specific culture

390

2.05

7.92

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

683

5688

1.36

7.89

2.0

1.9

1.42

1.34

mmol/l

1.39

579

4875

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

144

2.75

7.80

2.2

15.33

26.35

mg/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

318

2.16

7.79

1.4

1.5

64.23

31.28

e6/l

0.36

238

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

361

2.07

7.64

3.6

3.3

0.37

0.38

iu/ml

0.11

193

(4198724) Urine methamphetamine measurement

3.75

7.64

7.2

1.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

158

2.64

7.56

1.3

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

10.08

7.53

1.1

0.01

0.02

u/ml

—

(3000494) Fungus identified in Specimen by Culture

240

1672

1.52

7.53

1.7

1.4

—

(1002224) Polysomnography panel

116

676

1.77

7.44

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1389

13065

1.60

7.43

5.8

4.8

1.46

1.50

mmol/l

3.93

1308

12190

(3023511) Choriogonadotropin [Units/volume] in Urine

386

2.02

7.41

1.6

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

388

2.01

7.31

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

395

2.00

7.31

1.2

—

(3002256) Pathology report gross observation

251

1776

1.49

7.30

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

327

2.10

7.27

1.2

1.1

3.01

3.00

u/ml

0.00

178

(1001926) Buprenorphine [Presence] in Urine by Screen method

510

1.88

7.26

3.9

1.9

—

(3011288) Drugs identified in Urine by Screen method Nominal

462

1.91

7.15

3.5

2.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.79

7.09

1.1

2.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

529

1.85

7.08

2.6

1.8

—

(3042936) Bacteria identified in Isolate by Culture

265

1910

1.47

7.01

2.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

272

2.18

6.98

1.1

3.20

1.98

u/ml

0.33

141

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

165

1079

1.59

6.85

2.2

2.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.80

6.65

2.3

2.2

7.41

7.49

g/l

0.18

499

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

128

2.69

6.60

1.1

—

(3004451) EKG impression Narrative

3.28

6.57

1.4

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

118

717

1.70

6.55

3.1

2.2

6151.95

5429.44

u/l

0.07

294

(3004588) Protein electrophoresis panel - Serum or Plasma

141

898

1.63

6.53

2.6

2.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

363

1.97

6.48

1.2

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.53

6.44

2.0

4.2

106.75

164.24

umol/l

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

546

1.79

6.41

2.3

2.2

3.60

3.76

g/l

0.42

499

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

172

2.42

6.40

1.7

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.78

6.37

2.3

2.2

4.21

4.27

g/l

0.35

499

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

223

2.24

6.36

1.3

1.2

3.50

5.41

u/ml

0.65

101

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

511

1.81

6.32

2.3

2.2

2.92

2.99

g/l

0.28

463

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

189

1298

1.52

6.32

2.5

2.1

—

(3022313) Gas panel - Capillary blood

564

1.77

6.30

4.3

3.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

174

2.39

6.25

1.7

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

235

1703

1.45

6.01

1.7

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

203

2.25

5.99

7.3

5.9

366.74

364.84

umol/l

0.03

181

(3009508) Creatinine [Moles/volume] in Urine

556

4627

1.31

5.98

3.2

3.4

7.23

7.30

mmol/l

0.13

438

3960

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

189

1315

1.50

5.94

3.4

4.2

33.93

12.32

ug/l

0.38

147

1063

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

3.70

5.93

1.2

1.1

99.39

108.51

0.64

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

101

2.80

5.91

1.1

1.45

0.34

nmol/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

173

2.35

5.86

1.8

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

107

654

1.68

5.83

3.4

2.0

—

(3002179) Metamyelocytes/Leukocytes in Blood

172

1180

1.51

5.78

4.4

4.3

0.81

0.66

0.41

332

(3049717) Cytology report of Urine Cyto stain

400

1.87

5.77

2.6

—

(3003181) Sodium [Moles/volume] in Urine

267

2.06

5.73

1.4

1.3

68.25

58.42

mmol/l

0.74

219

(3040151) Glucose [Moles/volume] in Capillary blood

132

2.53

5.72

4.6

7.0

6.98

7.27

mmol/l

0.21

108

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

560

1.72

5.63

1.8

2.0

1.49

g/l

0.01

497

(3014133) Dog dander IgE Ab [Units/volume] in Serum

235

2.12

5.63

1.0

1.1

5.20

5.65

u/ml

0.06

112

(3026361) Erythrocytes [#/volume] in Blood

1504

14585

2.01

5.52

39.7

23.1

4.47

4.46

e12/l

0.27

1487

14288

(3010813) Leukocytes [#/volume] in Blood

1504

14586

2.01

5.50

39.8

23.1

6.90

6.75

e9/l

1.19

1488

14285

(3027008) Opiates [Presence] in Urine

106

657

1.66

5.49

3.4

2.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.65

5.49

1.5

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

211

2.17

5.48

1.1

6.16

7.43

u/ml

0.17

(3016879) Cocaine [Presence] in Urine

603

1.69

5.48

3.1

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

238

2.09

5.46

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

225

2.12

5.44

1.4

1.7

0.77

0.73

g/l

0.09

179

(3028300) Cannabinoids [Presence] in Urine

106

660

1.65

5.40

3.6

2.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

168

1164

1.50

5.39

1.5

—

(3007461) Platelets [#/volume] in Blood

1503

14580

1.98

5.38

39.8

23.1

259.06

256.69

e9/l

0.76

1490

14322

(3034860) Kappa light chains.free [Mass/volume] in Serum

419

1.80

5.29

3.3

3.7

39.64

59.58

mg/l

0.72

358

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

419

1.80

5.29

3.2

3.7

38.02

59.55

mg/l

0.78

357

(40768443) Skin Pathology biopsy report

609

1.67

5.29

1.1

1.2

—

(4268621) Lupus anticoagulant assay

156

2.34

5.28

2.2

—

(3002619) Bacteria identified in Specimen by Culture

5.04

5.25

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

209

2.14

5.20

1.2

—

(3027944) Amphetamines [Presence] in Urine

104

653

1.64

5.14

3.5

1.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

165

2.27

5.10

1.6

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

485

1.73

5.07

2.0

2.2

9.37

10.36

g/l

1.36

435

(3005988) Vibrio sp identified in Specimen by Organism specific culture

166

2.26

5.03

1.6

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

274

1.97

5.01

1.5

1.6

—

(3000330) Specific gravity of Urine by Test strip

109

697

1.61

5.01

3.8

3.5

1.02

ratio

0.55

638

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

186

2.18

5.00

1.6

1.4

5.71

0.18

nmol/l

0.49

137

(3021440) Promyelocytes/Leukocytes in Blood

169

1191

1.47

4.99

5.0

4.6

0.10

0.11

0.08

302

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

148

2.33

4.96

1.4

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

103

653

1.62

4.91

5.8

3.6

48.59

48.03

0.08

103

639

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

407

1.78

4.89

2.0

2.2

0.08

0.02

g/l

0.48

366

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

182

1307

1.44

4.87

2.5

2.2

0.22

0.21

g/l

0.78

164

1222

(3042517) Benzodiazepines panel - Urine

7.73

4.85

3.6

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

125

832

1.55

4.85

1.3

1.4

26.98

27.60

iu/l

0.07

105

710

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

3.01

4.83

1.2

1.5

—

78.00

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.86

4.81

1.4

1.3

1.21

1.18

mmol/l

0.62

(3016650) Hepatitis A virus Ab [Presence] in Serum

230

2.03

4.78

1.1

—

(3025159) Blasts/Leukocytes in Blood

169

1201

1.46

4.78

5.2

4.9

0.14

0.42

0.47

277

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.69

4.76

1.8

2.0

268.79

219.53

e6/l

0.62

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

381

1.79

4.75

2.7

3.5

1.32

3.10

ratio

1.09

214

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.70

4.68

1.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

165

2.21

4.67

1.6

1.4

—

(4195642) Thrombophilia screening test

192

2.11

4.64

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

213

2.05

4.60

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

476

1.70

4.59

2.3

2.4

0.57

1.14

g/l

1.08

408

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.55

4.56

1.0

1.1

100.00

100.35

0.02

(3017181) Myelocytes/Leukocytes in Blood

173

1248

1.43

4.53

5.0

4.5

1.53

1.02

0.64

360

(3004716) Salmonella sp identified in Stool by Organism specific culture

118

788

1.54

4.52

1.3

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

124

2.36

4.42

1.5

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

482

1.67

4.40

3.1

282.09

951.32

u/ml

0.95

424

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

370

1.76

4.32

2.0

2.2

0.00

g/l

-0.00

347

(3006184) Hemoglobin [Mass/volume] in Capillary blood

326

1.81

4.30

2.3

2.1

135.74

129.34

g/l

1.40

270

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.97

4.29

2.2

2.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

139

2.26

4.26

1.5

1.6

—

(3018333) Ribosomal P Ab [Presence] in Serum

120

2.36

4.26

1.4

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.06

4.24

1.2

1.1

158.37

181.49

iu/ml

0.22

(3008401) Mugwort IgE Ab [Units/volume] in Serum

271

1.87

4.17

1.2

1.1

0.70

1.19

u/ml

0.45

112

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.68

4.16

1.3

1.2

110.86

80.65

u/l

0.69

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.55

4.14

1.4

2.1

—

(3019225) pH of Specimen

175

1286

1.41

4.14

4.2

4.0

7.37

7.36

0.72

125

933

(3003888) Timothy IgE Ab [Units/volume] in Serum

279

1.86

4.13

1.2

1.1

2.48

4.97

u/ml

0.99

147

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

122

2.32

4.12

1.5

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

223

1.95

4.08

1.2

—

(3012516) Albumin [Mass/volume] in Urine

495

4218

1.25

4.08

3.1

3.5

49.93

42.39

mg/l

0.23

281

2638

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

266

1.87

4.07

6.5

5.6

416.00

296.70

iu/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

439

1.67

4.04

1.9

2.1

2.15

16.82

iu/l

0.60

182

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

124

2.28

3.98

1.4

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.55

3.97

1.4

2.0

542.47

598.41

e6/l

0.16

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

150

1082

1.43

3.94

3.5

3.6

1.23

mmol/l

0.01

131

922

(1616796) Gas panel - Central venous blood

270

1.84

3.90

3.1

3.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.81

3.87

1.8

2.2

—

(3012501) Base excess in Blood by calculation

249

1.87

3.87

3.5

3.6

1.97

2.73

mmol/l

1.73

165

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

7.30

3.86

1.0

1.2

—

(4062490) Immunoglobulin typing, IgG

139

2.18

3.84

1.5

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

399

1.68

3.84

2.0

2.2

0.00

g/l

-0.00

348

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.62

3.81

1.3

1.2

41.05

16.78

u/l

1.44

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

470

1.63

3.80

1.8

1.5

0.06

0.07

iu/ml

0.08

(3038177) Helicobacter pylori Ab [Presence] in Serum

229

1.90

3.80

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

127

2.23

3.78

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

127

2.23

3.78

1.4

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

181

2.01

3.75

1.5

1.4

—

nmol/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

472

1.62

3.74

1.4

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

202

1.95

3.74

1.1

1.55

0.25

u/ml

0.47

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

480

1.61

3.74

1.9

1.78

1.90

ug/l

0.03

426

(3020682) Albumin/Creatinine [Ratio] in Urine

501

4310

1.24

3.73

3.6

4.1

8.52

7.90

mg/mmol

0.10

262

2635

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

309

2515

1.29

3.68

1.8

1.7

—

(3023410) Appearance of Cerebral spinal fluid

142

2.13

3.66

1.3

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

2.39

3.66

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

218

1.90

3.65

1.3

1.1

3.26

2.47

eliau/ml

0.25

(3011412) CD3 cells [#/volume] in Blood

124

2.20

3.55

1.5

2.0

1526.00

1252.18

e6/l

0.71

110

(3028192) IgG subclass 2 [Mass/volume] in Serum

139

2.11

3.44

1.5

1.3

2.90

2.75

g/l

0.21

100

(3027135) IgG subclass 1 [Mass/volume] in Serum

139

2.11

3.44

1.5

1.3

5.84

6.82

g/l

1.26

102

(3024139) IgG subclass 3 [Mass/volume] in Serum

139

2.11

3.44

1.5

1.3

0.35

0.38

g/l

0.24

101

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

230

1.85

3.44

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

4.57

3.43

1.3

2.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

133

2.13

3.40

1.4

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.10

3.39

1.5

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

107

2.26

3.39

1.3

1.2

62.00

189.41

titre

—

(3011897) Casein IgE Ab [Units/volume] in Serum

5.02

3.37

1.1

0.01

0.06

u/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

479

1.57

3.32

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

128

2.13

3.30

1.4

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.93

3.30

1.3

1.6

14.50

14.68

pmol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

102

2.27

3.30

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

129

2.11

3.25

1.6

1.3

2.64

1.16

u/ml

0.30

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

349

1.66

3.21

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.39

3.18

1.0

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

3.45

3.10

1.3

2.0

0.17

0.19

e9/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

105

2.21

3.10

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

112

2.16

3.07

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

285

1.71

3.04

1.1

16.60

16.44

au/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

197

1.85

2.99

1.7

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

331

2786

1.24

2.94

1.6

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

251

1.73

2.90

1.5

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

3.45

2.90

1.0

1.1

26.01

43.72

iu/ml

0.45

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

447

1.55

2.89

4.3

3.8

24.64

24.88

mmol/l

0.23

416

(3044941) Cell count panel - Synovial fluid

259

1.72

2.89

1.6

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.72

2.88

1.9

2.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.60

2.87

1.4

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.40

2.87

1.0

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

201

1.81

2.82

1.5

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

231

1.75

2.81

1.8

2.1

5.20

4.94

umol/l

0.10

174

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

247

1.72

2.78

1.7

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

181

1.84

2.75

1.3

1.4

296.32

351.24

pmol/l

0.76

160

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

349

1.60

2.73

1.8

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.02

2.73

1.3

1.6

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

153

1.91

2.71

1.7

1.6

50.00

61.03

0.64

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.29

2.68

1.4

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.68

2.60

1.0

1.4

—

(3017509) Phencyclidine [Presence] in Urine

4.68

2.60

1.6

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

185

1.80

2.58

1.4

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.07

2.56

2.7

2.2

13.35

17.29

umol/l

0.65

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.24

2.54

1.3

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

2.24

2.54

1.1

1.0

0.43

0.28

u/ml

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.61

2.53

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

108

2.05

2.52

1.1

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

172

1.82

2.51

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

588

1.43

2.49

1.5

1.7

286.69

310.21

mu/l

0.38

534

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.12

2.49

1.7

1.2

74.55

74.54

umol/l

0.00

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

240

1.68

2.49

1.6

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.56

2.44

1.0

2.92

13.40

u/ml

—

(3017569) Oxygen content in Arterial blood

2.36

2.39

1.2

2.8

15.17

16.35

0.42

(3000475) Leukocytes [#/volume] in Synovial fluid

346

1.55

2.37

1.8

1.6

5898.62

12921.10

e6/l

1.52

242

(3051387) C reactive protein [Mass/volume] in Capillary blood

275

1.62

2.36

5.9

3.6

18.17

24.09

mg/l

0.75

187

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.51

2.36

1.4

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

4.13

2.36

1.6

3.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.10

2.33

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

348

1.54

2.32

1.8

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

167

1340

1.28

2.25

3.4

3.0

0.61

0.75

ug/l

1.99

118

816

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.16

2.25

1.1

1297.06

1643.89

miu/ml

0.75

(4133840) Spirometry

3.12

2.22

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

100

2.01

2.21

1.9

1.6

38.15

34.67

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.87

2.21

1.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

136

1.85

2.18

3.8

2.0

1.37

0.73

mmol/l

0.54

131

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

282

1.58

2.15

1.1

1.2

160.08

233.71

u/ml

1.35

166

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.63

2.14

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.79

2.14

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

213

1770

1.24

2.13

1.7

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

109

1.94

2.11

1.6

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

102

1.97

2.10

2.0

3.0

160.49

12.74

mg/l

0.47

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

390

1.48

2.09

2.8

3.0

—

(3028433) Virus identified in Specimen by Culture

2.57

2.08

1.0

1.2

—

(3047189) Immunofixation for 24 hour Urine

2.33

2.05

1.2

1.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.01

2.04

1.0

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.97

2.00

1.1

1.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

330

2880

1.19

1.99

1.8

1.7

164236547.90

26148555.38

pmol/l

1.02

288

2417

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

186

1.68

1.98

1.1

1.42

1.51

g/l

0.79

170

(3012441) Differential panel - Pleural fluid

106

1.90

1.91

1.6

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.93

1.90

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

102

786

1.32

1.89

2.9

2.4

11.58

12.49

nmol/l

0.50

722

(3000093) Morphology [Interpretation] in Blood Narrative

121

1.83

1.89

1.0

1.1

—

(3047181) Lactate [Moles/volume] in Blood

384

1.45

1.85

3.4

7.2

1.16

1.28

mmol/l

0.77

336

(3003694) ABO and Rh group [Type] in Blood

456

4110

1.16

1.82

1.6

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.13

1.82

1.9

1.4

31.40

29.28

umol/l

0.23

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

108

1.86

1.82

1.5

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

108

1.86

1.82

1.8

2.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

123

1.80

1.5

1.3

1067.47

1983.25

e6/l

1.81

(3025130) Human papilloma virus identified in Specimen

280

1.51

1.78

2.2

1.8

—

(3018133) Calcium [Moles/volume] in Urine

2.68

1.72

2.1

1.9

3.63

3.33

mmol/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

125

1.77

1.72

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

458

1.39

1.72

3.1

3.4

195.46

435.25

mg/l

1.00

182

(3009214) Lutropin [Units/volume] in Serum or Plasma

425

1.40

1.70

1.4

11.24

10.18

u/l

0.25

339

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

3.17

1.66

1.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.17

1.66

3.3

1.0

4.12

6.42

nmol/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

259

2250

1.18

1.65

5.3

5.1

1.72

2.23

ug/l

1.50

239

2043

(3037756) Immunofixation for Serum or Plasma

294

1.48

1.63

2.0

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.25

1.63

1.1

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

135

1.71

1.63

3.6

3.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

106

1.80

1.59

1.5

1.4

8953.50

112638.47

e6/l

0.80

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

189

1604

1.20

1.57

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

272

1.48

1.57

3.7

3.5

0.88

0.85

nmol/l

0.17

225

(21494755) Public health laboratory ask at order entry panel

104

1296

0.79

1.57

1.2

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

364

1.41

1.56

1.9

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

273

1.48

1.55

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

273

1.48

1.55

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

273

1.48

1.55

1.2

1.4

—

(4146454) Self-monitoring of blood glucose

122

1.73

1.55

2.4

2.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

153

1.64

1.53

1.6

1.5

19.86

24.26

ng/l

0.70

153

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.34

1.52

1.8

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

225

1.52

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.60

1.51

1.0

1.1

15.02

16.33

umol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.60

1.51

1.3

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

188

1602

1.20

1.50

5.3

4.8

32.54

32.66

0.05

125

1090

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.86

1.50

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.86

1.50

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.86

1.50

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.86

1.50

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

558

1.32

1.49

1.4

1.3

206.31

230.58

miu/ml

0.21

276

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.44

1.48

1.0

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

227

1.51

1.47

1.4

—

10.40

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.98

1.43

1.3

1.5

177.38

161.74

mmol/24h

0.17

(44790047) Parainfluenza type 1 nucleic acid detection

188

1.55

1.43

2.0

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

188

1.55

1.43

2.0

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

188

1.55

1.43

2.0

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

188

1.55

1.43

2.0

1.4

—

(3034426) Prothrombin time (PT)

2.32

1.43

1.1

1.3

26.78

28.08

—

(21494890) Protein electrophoresis panel - 24 hour Urine

118

1.70

1.41

1.5

2.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

207

1790

1.18

1.41

4.5

4.2

21.30

21.54

0.08

793

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.42

1.39

1.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

104

1.74

1.37

1.1

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

315

1.41

1.36

1.8

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

128

1063

1.22

1.35

2.4

2.5

76.88

68.77

ml/min/173m2

1.49

468

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

184

1.53

1.32

1.4

1.5

398.65

342.39

mu/l

0.17

152

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

168

1.56

1.32

1.7

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.10

1.30

4.7

2.0

40.02

41.19

g/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.85

1.30

1.3

2.6

6.50

8.50

mmol/l

2.70

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

114

1.67

1.28

1.3

1.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.01

1.27

2.6

2.3

17.68

174.19

ug/l

0.50

(3045142) Bone marrow Pathology biopsy report

146

1.58

1.26

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.75

1.25

1.4

—

67.78

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.64

1.21

1.8

3.4

—

(3008295) Osmolality of Serum or Plasma

173

1.51

1.18

1.5

1.4

276.25

276.21

mosm/kgh2o

0.00

127

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

165

1.52

1.18

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

248

1.42

1.17

1.2

1.4

139.93

156.90

au/ml

0.44

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

190

1.48

1.16

1.5

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.85

1.13

1.6

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.85

1.13

1.6

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.85

1.13

1.6

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.85

1.13

1.6

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.76

1.13

1.6

1.3

3.94

6.04

umol/l

1.21

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

143

1.55

1.11

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

1.71

1.11

1.5

2.5

46.89

42.63

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.97

1.11

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

104

1.64

1.09

1.9

2.1

3.92

1.97

u/field

0.69

(4034850) Laboratory test

409

1.31

1.07

12.7

9.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.13

1.05

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

383

0.70

1.05

1.7

1.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.67

1.04

1.9

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

315

1.34

1.03

4.7

4.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

146

1.51

1.03

1.2

1.3

—

(3024263) Appearance of Synovial fluid

1.84

1.03

2.3

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.92

1.02

1.6

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.92

1.02

1.6

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

1.77

1.00

1.0

1.3

145.75

148.66

nmol/l

0.07

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.88

1.00

1.6

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.88

1.00

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

1.62

1.00

1.5

1.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.84

0.98

2.4

2.6

8.18

10.26

mg/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

536

0.76

0.97

1.2

1.1

1.47

1.56

g/l

1.67

536

(3017704) Immunofixation for Urine

1.74

0.96

2.7

1.6

—

(40768793) Breast Pathology biopsy report

426

1.28

0.95

1.3

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.77

0.94

1.7

24.78

29.55

—

(40761536) Microorganisms panel - Urine sediment

132

1143

1.17

0.94

6.2

3.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.78

0.94

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.90

0.94

1.1

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

117

1.54

0.94

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

117

1.54

0.94

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

117

1.54

0.94

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.23

0.93

2.8

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.23

0.93

2.2

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

895

0.82

0.93

1.5

1.6

1187.28

1000.53

mu/l

0.25

766

(3006462) Nitrate [Presence] in Urine

1.73

0.92

4.2

2.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

244

1.36

0.91

1.4

1.3

19.52

23.43

u/l

0.41

204

(4027681) Cerebrospinal fluid IgG ratio and IgG index

1.63

0.91

1.4

1.2

0.55

ratio

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

168

1.44

0.90

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

315

1.31

0.89

3.4

56.40

58.62

0.50

315

(3051611) Lipemic interference index of Serum or Plasma

127

1.50

0.88

3.4

2.9

22.10

12.48

index

—

(3001019) Free T4 and TSH panel - Serum or Plasma

778

1.19

0.88

2.1

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.00

0.87

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.87

1.2

—

(3000285) Sodium [Moles/volume] in Blood

2.00

0.87

2.3

1.1

135.00

139.36

mmol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.74

0.82

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

387

0.74

0.82

1.6

1.5

—

(3022689) Creatine [Moles/volume] in Urine

1.88

0.82

1.5

1.6

13.19

7.87

mmol/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.88

0.82

1.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

374

1.26

0.80

1.6

1.4

—

(3023419) Bacteria identified in Sputum by Culture

181

1.39

0.80

2.8

—

(4211845) Urine protein measurement

1.73

0.79

4.2

2.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

207

1.36

0.79

1.7

1.4

—

(1761868) Lipid panel - Serum or Plasma

558

5301

1.08

0.79

3.3

3.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.78

0.0

1.3

—

66.50

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

131

1.46

0.78

2.0

3.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

594

1.20

0.78

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

245

0.69

0.77

1.2

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.60

0.75

1.2

1.0

0.66

0.29

u/ml

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.09

0.74

1.4

1.7

4.74

1400003.88

nmol/l

—

(3048879) Bone marrow aspiration report

2.09

0.74

1.6

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.67

0.74

2.0

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.00

0.72

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

142

1.41

0.72

1.6

2.6

2.14

1.26

g/24h

0.52

(3014271) Vancomycin [Susceptibility]

1.58

0.71

3.2

2.3

—

(21494434) Karyotype in Bone marrow

109

1.47

0.71

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

109

1.47

0.71

1.3

—

(4015189) Microbial culture of sputum

1.93

0.70

1.8

3.4

—

(3005033) Fetal Nuchal fold Thickness US

376

0.77

0.70

1.6

1.5

1.40

1.27

0.53

277

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.71

0.70

1.4

1.2

240.00

306.71

pmol/l

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.85

0.68

1.0

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

411

1.22

0.67

1.4

1.5

69.44

220.67

pmol/l

2.70

401

(3043238) Trisomy 21 risk [Likelihood] in Fetus

395

0.78

0.66

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

416

0.79

0.65

1.4

1.7

—

(4035726) Immunohistochemistry procedure

126

1124

1.13

0.65

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

270

1.27

0.62

1.7

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

406

1.21

0.62

2.8

3.2

1.31

1.47

mg/l

0.97

371

(3044927) Protein electrophoresis panel - Urine

138

1.38

0.62

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

322

0.77

0.60

1.4

1.6

55.19

58.86

ug/l

0.20

322

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.54

0.59

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.54

0.59

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.59

0.0

5.0

—

7.68

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.59

0.0

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.53

0.59

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.72

0.57

1.0

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.72

0.57

1.0

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

158

1.33

0.57

2.0

2.3

33.48

32.29

0.94

158

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

256

1.26

0.57

1.5

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

1.67

0.56

1.7

1.3

84.12

79.30

mu/l

—

(3000012) Reticulocyte production index

176

1.31

0.56

1.7

2.3

1.02

0.92

0.33

116

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

148

1347

1.11

0.56

4.6

3.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.58

0.54

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.45

0.52

1.5

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

109

1.38

0.51

2.1

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.42

0.50

1.0

—

(44806420) Estimation of glomerular filtration rate

155

0.71

0.48

2.5

2.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.49

0.47

1.4

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

473

0.84

0.47

1.5

0.87

1.15

ratio

1.92

296

(3043410) Blood group antigens tested for on Red Blood Cells

1.46

0.46

2.0

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

367

1.18

0.44

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

576

0.86

0.44

1.3

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

130

1.31

0.44

1.1

—

(3042631) Mycobacterium sp identified in Specimen

157

1.28

0.43

2.4

2.8

—

(40768795) Lymph node Pathology biopsy report

127

0.71

0.43

1.3

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.36

0.41

1.7

1.6

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.2

—

166.28

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.47

0.40

1.2

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.47

0.40

1.0

1.1

1.13

2.08

u/ml

—

(3005570) Glucose [Moles/volume] in Urine

141

1.28

0.40

1.9

2.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.39

0.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

463

0.86

0.39

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

124

1.29

0.38

2.1

1.3

7076.27

199173.15

e6/l

1.45

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

133

1.28

0.38

1.1

111.82

112.35

pmol/l

0.02

133

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

473

0.86

0.38

1.5

0.98

0.94

ratio

0.33

296

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

473

0.86

0.38

1.5

1.00

1.22

ratio

1.05

296

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.33

0.37

1.7

1.2

7.00

8.12

mm/h

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.39

0.37

1.5

1.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.39

0.37

1.1

—

12.60

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.39

0.37

1.5

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

157

1471

1.07

0.36

5.9

6.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

566

1.12

0.34

1.6

1.7

4.68

4.94

mg/l

0.05

408

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.37

0.34

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.37

0.34

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.37

0.34

1.0

1.5

42.50

705.25

nmol/24h

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.37

0.34

2.5

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

237

1.18

0.33

1.1

1.2

14.98

22.49

u/l

0.90

205

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

136

1.25

0.33

5.8

5.0

329.88

63.13

u/ml

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

509

0.88

0.33

1.5

41.91

61.23

ug/l

3.52

440

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.31

0.33

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.31

0.33

2.3

2.5

0.66

0.61

mmol/l

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.31

0.33

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.31

0.33

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.31

0.33

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.33

0.32

1.4

1.8

80.73

104.49

ng/l

0.95

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

542

0.90

0.27

1.6

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

123

1.22

0.25

1.2

1.1

16.08

16.31

u/ml

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.19

0.24

1.3

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

110

1165

0.94

0.23

1.5

1.7

3.49

3.46

mmol/l

0.10

807

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.32

0.23

2.0

2.8

4.60

4.64

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.32

0.23

2.0

2.8

12.48

10.18

kpa

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

285

0.88

0.23

1.6

1.5

0.24

0.37

nmol/l

1.03

231

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.28

0.23

1.6

1.4

13.24

9.27

ug/l

—

(3051651) Icteric interference index of Serum or Plasma

1.27

0.22

3.9

3.1

0.30

0.80

index

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3044007) Cell count panel - Peritoneal fluid

1.16

0.21

1.6

2.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.20

0.0

1.2

—

7.00

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

4.62

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.25

0.20

1.5

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.23

0.20

2.8

4.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.24

0.18

1.5

1.2

—

(3012565) Volume of 24 hour Urine

0.73

0.17

2.0

2.9

2430.00

1942.50

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

215

1.12

0.16

1.0

1.2

2.20

146.46

iu/ml

—

(40768441) Liver Pathology biopsy report

108

0.83

0.13

1.0

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

277

1.08

0.12

1.3

1.9

1.01

0.91

nmol/l

0.28

233

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

307

1.08

0.12

1.4

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

134

1.12

0.11

1.1

—

(3035715) Granulocytes [#/volume] in Blood

251

1.08

0.10

3.0

3.5

4.67

4.25

e9/l

0.36

251

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.04

0.09

1.6

1.1

42.80

42.11

u/ml

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

107

1.12

0.08

1.3

2.1

17.75

22.75

nmol/l

1.32

100

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

117

1.11

0.08

2.2

2.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.03

0.07

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.82

0.07

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

245

1.06

0.07

2.3

3.4

874.93

1517.55

u/ml

0.20

234

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

285

0.95

0.06

3.4

4.2

42.52

35.26

u/ml

0.13

278

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

156

1542

1.01

0.04

1.7

1.9

3.28

3.40

ratio

0.69

117

1175

(4281824) Cell count and differential, peritoneal fluid

179

0.95

0.03

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

138

1.01

0.00

1.3

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

278

1.01

0.00

2.0

2.4

33.68

88.59

ug/min

1.13

168

(40768800) Prostate Pathology biopsy report

133

0.98

0.00

1.1

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.3

—

170.13

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.4

—

0.14

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

0.48

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

8.6

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

37.05

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

7.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

-0.00

0.0

2.9

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.93

-0.00

1.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.88

-0.00

1.5

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

2.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.94

-0.00

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.00

-0.00

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.69

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

100

1.00

-0.00

1.7

1.6

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(4212803) Bone marrow aspirate examination

0.00

-0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.2

—

(3020650) Glucose [Presence] in Urine

0.98

-0.00

1.2

1.8

0.00

estimate

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.97

-0.00

1.3

4.5

1.50

1.23

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_TIETZE and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_TIETZE	1.184 [1.03, 1.36]	0.015
Birth year	0.996 [0.99, 1.01]	0.358

During the follow-up period (1.1.1998 — 31.12.2019), 704 out of 5082 females with M13_TIETZE died.

Males

Parameter	HR [95% CI]	p-value
M13_TIETZE	1.178 [0.96, 1.44]	0.113
Birth year	0.986 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 236 out of 2124 males with M13_TIETZE died.

Mortality risk

Mortality risk for people of age

years, who have M13_TIETZE.

N-year risk	Females	Males
1	0.131%	0.197%
5	0.686%	1.305%
10	1.56%	3.212%
15	3.269%	6.432%
20	5.964%	11.041%

Relationships between endpoints

↥

Index endpoint: M13_TIETZE – Chondrocostal junction syndrome [Tietze]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Chondrocostal junction syndrome [Tietze]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints